
Healthcare and life sciences M&A outlook: Bullish signals ahead
[Boston Business Journal] With both positive momentum and the competitive stakes so high, companies with the most knowledge, the greatest experience targeting innovative assets — and those that employ rapid and thorough due diligence — can prevail in this deal market.